Aims & Scope


Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma.

Metabolic Syndrome and Related Disorders coverage includes:

  • Insulin resistance
  • Central obesity
  • Glucose intolerance
  • Dyslipidemia with elevated triglycerides
  • Low HDL-cholesterol
  • Microalbuminuria
  • Predominance of small dense LDL-cholesterol particles
  • Hypertension
  • Endothelial dysfunction
  • Oxidative stress
  • Inflammation
  • Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout

Metabolic Syndrome and Related Disorders is under the editorial leadership of Editor-in-Chief Adrian Vella, MD, Mayo Clinic College of Medicine, MN, and other key investigators. View the entire editorial board.

Audience: Endocrinologists, metabolism researchers, and diabetes researchers, among others

Indexed/Abstracted in:

MEDLINE;

PubMed;

PubMed Central;

Science Citation Index Expanded;

Biological Abstracts;

BIOSIS Previews;

Journal Citation Reports/Science Edition;

EMBASE/Excerpta Medica;

Scopus;

Chemical Abstracts;

ProQuest databases;

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.